CORRESP 1 filename1.htm Correspondence
  

Katherine R. Kelly

Vice President & Assistant General Counsel

LOGO   
  

345 Park Avenue     New York, NY 10154-0037

Tel 212-546-4852    Fax 212-605-9475

katherine.kelly@bms.com

   August 27, 2010

VIA EDGAR

Mr. Jim B. Rosenberg

Senior Assistant Chief Accountant

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

 

  Re: Bristol-Myers Squibb Company
     Form 10-K for the Year Ended December 31, 2009
     Filed February 19, 2010
     File No. 1-1136

Dear Mr. Rosenberg:

We have received the comment letter (the “Comment Letter”) dated August 13, 2010 regarding the comment of the staff of the Securities and Exchange Commission (the “Commission”) with respect to the above referenced Annual Report on Form 10-K for the year ended December 31, 2009. We anticipate providing a complete response by September 1, 2010.

Sincerely,

/s/ Katherine R. Kelly

Katherine R. Kelly

Vice President & Assistant General Counsel

 

cc: Charles Bancroft, Bristol-Myers Squibb Company
   Sandra Leung, Bristol-Myers Squibb Company